5 news...
1. Antengene Receives Clinical Trial Approval in Australia for Phase I ATTRACT Study of ATG-201 (CD19 x CD3 TCE) in B Cell-related Autoimmune Diseases
News /PR Newswire /Antengene Receives Clinical Trial Approval in Australia for Phase I ATTRACT Study of ATG-201 (CD19 x CD3 TCE) in B Cell-related Autoimm… Antengene Receives Clinical Trial Approval in Australia for Phase I ATTRACT Study of ATG-201 (CD19...
tradingview.com
score:0.576, 2026-08-25 03:44:16
2. Antengene Receives Clinical Trial Approval in Australia for Phase I ATTRACT Study of ATG-201 (CD19 x CD3 TCE) in B Cell-related Autoimmune Diseases
SHANGHAI and HONG KONG, Aug. 24, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or...
prnewswire.com
score:0.534, 2026-08-25 03:40:05
3. Antengene Announces 2026 Interim Results: Achieves First‑Ever Profitability and Accelerates Value Creation Through Innovative R&D
SHANGHAI and HONG KONG, Aug. 23, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or...
prnewswire.com ...
score:0.637, 2026-08-24 04:23:54
4. Antengene Presents Key R&D Highlights at the Evercore 2nd China Biotech Summit
SHANGHAI and HONG KONG, Aug. 18, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or...
prnewswire.com ...
score:0.959, 2026-08-19 04:29:53
5. Antengene Presents Key R&D Highlights at the Evercore 2nd China Biotech Summit
News /PR Newswire /Antengene Presents Key R&D Highlights at the Evercore 2nd China Biotech Summit Antengene Presents Key R&D Highlights at the Evercore 2nd China Biotech Summit 6 min read SHANGHAI and HONG KONG, Aug. 19, 2026 /PRNewswire/ -- Antengene...
tradingview.com ...
score:1, 2026-08-19 04:29:22